Common Contracts
5 similar Exchange Agreement contracts by Hologic Inc, Omnicare Inc, Telecommunication Systems Inc /Fa/
EXCHANGE AGREEMENTExchange Agreement • May 2nd, 2013 • Telecommunication Systems Inc /Fa/ • Services-prepackaged software
(the “Undersigned”), for itself and on behalf of the beneficial owners listed on Exhibit A hereto (“Accounts”) for whom the Undersigned holds contractual and investment authority (each Account, as well as the Undersigned if it is exchanging Existing Notes (as defined below) hereunder, a “Holder”), enters into this Exchange Agreement (the “Agreement”) with TeleCommunication Systems, Inc. (the “Company”) on May , 2013 whereby the Holders will exchange (the “Exchange”) the Company’s 4.50% Convertible Senior Notes due 2014 (the “Existing Notes”) for the Company’s new % Convertible Senior Notes due 2018 (the “New Notes”) that will be issued pursuant to the provisions of an Indenture to be dated as of , 2013 (the “Indenture”) between the Company and The Bank of New York Mellon Trust Company, N.A., as Trustee (the “Trustee”).
EXCHANGE AGREEMENTExchange Agreement • February 15th, 2013 • Hologic Inc • X-ray apparatus & tubes & related irradiation apparatus
(the “Undersigned”), for itself and on behalf of the beneficial owners listed on Exhibit A hereto (“Accounts”) for whom the Undersigned holds contractual and investment authority (each Account, as well as the Undersigned if it is exchanging Existing Notes (as defined below) hereunder, a “Holder”), enters into this Exchange Agreement (the “Agreement”) with Hologic, Inc. (the “Company”) on February 15, 2013 whereby the Holder will exchange (the “Exchange”) the Company’s 2.00% Convertible Senior Notes due 2037 (the “Existing Notes”) for the Company’s new 2.00% Convertible Senior Notes due 2043 (the “New Notes”) that will be issued pursuant to the provisions of an Indenture dated as of December 10, 2007 (the “Base Indenture”) between the Company and Wilmington Trust Company, as Trustee (the “Trustee”), as supplemented by the Fourth Supplemental Indenture thereto, to be dated as of February 21, 2013 (the “Supplement,” and, together with the Base Indenture and all other supplements thereto,
EXCHANGE AGREEMENTExchange Agreement • March 29th, 2012 • Omnicare Inc • Retail-drug stores and proprietary stores
(the “Undersigned”), for itself and on behalf of the beneficial owners listed on Exhibit A hereto (“Accounts”) for whom the Undersigned holds contractual and investment authority (each Account, as well as the Undersigned if it is exchanging Existing Notes (as defined below) hereunder, a “Holder”), enters into this Exchange Agreement (the “Agreement”) with Omnicare, Inc. (the “Company”) on March , 2012 whereby the Holders will exchange (the “Exchange”) the Company’s 3.75% Convertible Senior Subordinated Notes due 2025 (the “Existing Notes”) for the Company’s new 3.75% Convertible Senior Subordinated Notes due 2042 (the “New Notes”) that will be issued pursuant to the provisions of an Indenture dated as of June 13, 2003 (the “Base Indenture”) between the Company and U.S. Bank National Association, as successor Trustee to SunTrust Bank (the “Trustee”), as supplemented by the Eighth Supplemental Indenture thereto, to be dated as of April , 2012 (the “Supplement,” and, together with the Bas
EXCHANGE AGREEMENTExchange Agreement • February 29th, 2012 • Hologic Inc • X-ray apparatus & tubes & related irradiation apparatus
(the “Undersigned”), for itself and on behalf of the beneficial owners listed on Exhibit A hereto (“Accounts”) for whom the Undersigned holds contractual and investment authority (each Account, as well as the Undersigned if it is exchanging Existing Notes (as defined below) hereunder, a “Holder”), enters into this Exchange Agreement (the “Agreement”) with Hologic, Inc. (the “Company”) on February 29, 2012 whereby the Holder will exchange (the “Exchange”) the Company’s 2.00% Convertible Senior Notes due 2037 (the “Existing Notes”) for the Company’s new 2.00% Convertible Senior Notes due 2042 (the “New Notes”) that will be issued pursuant to the provisions of an Indenture dated as of December 10, 2007 (the “Base Indenture”) between the Company and Wilmington Trust Company, as Trustee (the “Trustee”), as supplemented by the Third Supplemental Indenture thereto, to be dated as of March 5, 2012 (the “Supplement,” and, together with the Base Indenture and all other supplements thereto, the “
EXCHANGE AGREEMENT [Unrestricted Notes/Supplemental Indenture]Exchange Agreement • November 18th, 2010 • Hologic Inc • X-ray apparatus & tubes & related irradiation apparatus
(the “Undersigned”), for itself and on behalf of the beneficial owners listed on Exhibit A hereto (“Accounts”) for whom the Undersigned holds contractual and investment authority (each Account, as well as the Undersigned if it is exchanging Existing Notes (as defined below) hereunder, a “Holder”), enters into this Exchange Agreement (the “Agreement”) with Hologic, Inc (the “Company”) on November 18, 2010 whereby the Holder will exchange (the “Exchange”) the Company’s 2.00% Convertible Senior Notes due 2037 (the “Existing Notes”) for the Company’s new 2.00% Convertible Exchange Senior Notes due 2037 (the “New Notes”) that will be issued pursuant to the provisions of an Indenture dated as of December 10, 2007 (the “Base Indenture”) between the Company and Wilmington Trust Company, as Trustee (the “Trustee”), as supplemented by the Second Supplemental Indenture thereto, to be dated as of November 23, 2010 (the “Supplement,” and, together with the Base Indenture and all other supplements t
